Menu
History
Investor Showcase
Virtuoso unveils its newly designed system, and CEO and Chief Medical Officer Duke Herrell performs a live demonstration.
Initial Public Offering of Common Shares
Initial Public Offering to advance Virtuoso Surgical’s groundbreaking robotic system for endoscopic surgery becomes effective after review by the United States Securities and Exchange Commission and the Financial Industry Regulatory Authority.
Successful Cadaver Experiments for Central Airway Obstruction Removal
Virtuoso completes 30 experiments in both male and female cadavers on removing tumors obstructing the central airway.
Richard Hendrick Presents at the American Association for Bronchology and Interventional Pulmonology Conference
Virtuoso founder Richard Hendrick presents an invited lecture at the 2022 AABIP and describes the Virtuoso System to physicians focusing on lung interventions.
Unveiling of Virtuoso at the American Urological Association Conference
Virtuoso debuts our robotic system publicly to the medical community at our booth at the AUA annual meeting.
First Live Animal Experiments
Virtuoso completes first experiments in live animals. These experiments demonstrated successful tissue resection from the animal’s uterus.
First Cadaver TURBT Experiments
Virtuoso completes successful experiments in a cadaver bladder, simulating the Transurethral Resection of Bladder Tumor (TURBT) procedure. Virtuoso also completes successful prostate tissue resections in a cadaver at the same time.
First Ex Vivo Animal Uterine Surgery
Virtuoso performs successful experiments in an ex vivo uterine animal tissue model. These experiments are subsequently published in the Journal of Minimally Invasive Gynecology and nominated for a best video award at the American Association of Gynecologic Laparoscopists annual meeting.
Initial Public Offering of Preferred Shares
Initial Public Offering to advance Virtuoso Surgical’s groundbreaking robotic system for endoscopic surgery becomes effective after review by the United States Securities and Exchange Commission and the Financial Industry Regulatory Authority.
Virtuoso Receives SBIR Phase II Grant
Virtuoso Surgical receives a grant from the National Heart, Lung, and Blood Institute to further study the use of Virtuoso's technology to treat central airway obstructions.
First Cadaver Experiments
Virtuoso publishes a collaboration with surgeons at Vanderbilt University Medical Center establishing the feasibility of using Virtuoso's technology to treat central airway obstructions secondary to lung cancer. Virtuoso's technology was shown to reduce force on the patient's head and neck and is likely to reduce complications from the procedure.
Virtuoso Profiled in MedTech Strategist
MedTech Strategist names Virtuoso a "Startup to Watch" in its January issue.
Robert Webster Presents at the Congress of Neurological Surgeons
Virtuoso founder Robert Webster visits the 2018 Congress of Neurological Surgeons to present neurosurgical applications of the Virtuoso technology.
Mark Pickrell Presents at MedTech Strategist
Virtuoso founder Mark Pickrell visits MedTech Strategist to present Virtuoso's technology to potential investors.
Duke Herrell Presents at the World Congress of Endourology
Virtuoso founder Duke Herrell visits the 2018 World Congress of Endourology to present an update on the Virtuoso technology for urologic applications.
Virtuoso Founders Present at American Urologic Association
Robert Webster and Duke Herrell visit the American Urologic Association's Annual Meeting to present about Virtuoso's potential treatment for benign prostatic hyperplasia.
Virtuoso Receives STTR Phase I Grant
Virtuoso Surgical receives an STTR award from the National Heart, Lung, and Blood Institute. The award will fund the application of Virtuoso's technology to treat central airway obstructions.
Virtuoso Receives SBIR Matching Grant
Virtuoso Surgical receives an SBIR Matching Grant Award from Launch Tennessee. The State award will accelerate progress and promote growth in Tennessee.
Virtuoso Receives SBIR Phase II Grant
Virtuoso Surgical receives a Notice of Award from the National Institute of Biomedical Imaging and Bioengineering. The NIH award is expected to fund prototype development, testing, and regulatory approval efforts for a two-year period.
Virtuoso Begins Formal Operations
Virtuoso Surgical begins formal operations and opens its engineering offices and laboratory in Nashville, Tennessee, for development of its endoscopic surgical device.
Virtuoso Surgical, Inc. Founded
Virtuoso Surgical, Inc. is incorporated by Dr. Webster, Dr. Herrell, Dr. Hendrick, and Mark Pickrell to commercialize a surgical device using concentric tube technology.